Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-24

Clinical Trial Update: Efficacy and Safety Assessment of Botulax® and BOTOX® for Improvement of Glabellar Lines. [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of Botulax and BOTOX for improvement of glabellar lines has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botox (OnabotulinumtoxinA)
  • Botulax (botulinum toxin type A)

Snippet

Sponsor: Hugel | Conditions: Glabellar Lines | Phase 3 | Status: COMPLETED